These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28776437)

  • 1. Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements?
    Teruel RS; Thue G; Fylkesnes SI; Sandberg S; Kristoffersen AH
    Scand J Prim Health Care; 2017 Sep; 35(3):299-306. PubMed ID: 28776437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postanalytical external quality assessment of warfarin monitoring in primary healthcare.
    Kristoffersen AH; Thue G; Sandberg S
    Clin Chem; 2006 Oct; 52(10):1871-8. PubMed ID: 16916987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert system.
    Lin SW; Kang WY; Lin DT; Lee J; Wu FL; Chen CL; Tseng YJ
    BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S13. PubMed ID: 25079609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia and risk of adverse warfarin-related events in the nursing home setting.
    Tjia J; Field TS; Mazor KM; Donovan JL; Kanaan AO; Reed G; Doherty P; Harrold LR; Gurwitz JH
    Am J Geriatr Pharmacother; 2012 Oct; 10(5):323-30. PubMed ID: 23063288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the management of warfarin in aged-care facilities utilising innovative technology: a proof-of-concept study.
    Bereznicki LR; Jackson SL; Kromdijk W; Gee P; Fitzmaurice K; Bereznicki BJ; Peterson GM
    Int J Pharm Pract; 2014 Feb; 22(1):84-91. PubMed ID: 23581399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approach.
    Field TS; Tjia J; Mazor KM; Donovan JL; Kanaan AO; Harrold LR; Reed G; Doherty P; Spenard A; Gurwitz JH
    Am J Med; 2011 Feb; 124(2):179.e1-7. PubMed ID: 21295198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of warfarin therapy in the nursing home setting.
    Gurwitz JH; Field TS; Radford MJ; Harrold LR; Becker R; Reed G; DeBellis K; Moldoff J; Verzier N
    Am J Med; 2007 Jun; 120(6):539-44. PubMed ID: 17524757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Over-Anticoagulation in Warfarin Users in the UK General Population: A Nested Case-Control Study in a Primary Health Care Database.
    Martín-Pérez M; Gaist D; de Abajo FJ; García Rodríguez LA
    Thromb Haemost; 2019 Jan; 119(1):66-76. PubMed ID: 30597501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.
    Witt DM; Delate T; Clark NP; Martell C; Tran T; Crowther MA; Garcia DA; Ageno W; Hylek EM;
    J Thromb Haemost; 2010 Apr; 8(4):744-9. PubMed ID: 20398186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flucloxacillin-warfarin interaction: an under-appreciated phenomenon.
    Chaudhuri A; Wade SL
    Intern Med J; 2018 Jul; 48(7):860-863. PubMed ID: 29984514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated International Normalized Ratio in a patient concurrently using warfarin and vismodegib.
    Lim S; Houranieh J; Crawford R
    Am J Health Syst Pharm; 2014 Feb; 71(3):200-3. PubMed ID: 24429012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.